With severe asthma, the weight of symptoms is not just a burden for the patient. The process of identifying the right treatment for the right patient phenotype is also a burden for the HCP. Tezepelumab will be game-changing for severe asthma. This campaign will speak loud, speak big, and speak boldly about just how different a better treatment for severe asthma can be. It’s time to rise above and beyond where you’ve been.
Creative collaboration for Wunderman Thompson Health NY